Not So Easy

Elias Zerhouni, the former National Institutes of Health director who now heads up R&D at Sanofi-Aventis, has found that translational medicine is more difficult than he'd expected, reports the Wall Street Journal's Health Blog. Zerhouni, the Health Blog notes, pushed for better translational medicine. Upon joining Sanofi, "I thought the solution would be simple," Zerhouni said at a press event.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.

Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.

The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.

In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.